Nyeste anskaffelser der leverandøren GlaxoSmithKline AS nevnes
2022-07-08Rotavirus vaccine (Folkehelseinstituttet)
Folkehelseinstituttet (FHI) [the Norwegian Institute of Public Health (NIPH)] is implementing an open tender competition for the procurement of vaccine against rotavirus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q1 2023.
The scope of the procurement is estimated at a number of doses sufficient to fully immunise up to 65,000 infants in need in the Norwegian child vaccination programme per calendar year. The estimated total scope for the contract …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline AS
2020-07-07HPV Vaccine in the Child Vaccination Program (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health’is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of HPV vaccines i.e. The vaccine against human papillomavirus, for boys and girls in the Norwegian child vaccination program.
The competition will be implemented as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in CTM electronic tender …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline AS
2019-04-16Hexavalent Vaccine — A Combination Vaccine against Diphtheria, Tetanus, Whooping Cough, Polio, Hib and Hepatitis B (Folkehelseinstituttet)
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline AS
2018-06-14Rota virus vaccine, new notice (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline AS
2018-01-08Flu pandemic vaccines (Folkehelseinstituttet)
The Norwegian Institute of Public Health (FHI) is planning, on behalf of the Ministry of Health and Care Services (HOD), to hold an open tender contest for the procurement of vaccines against pandemic influensa for the Norwegian population. The intention of this procurement is to ensure inhabitants in Norway access to the vaccination in the event of pandemic influensa in the contract period.
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline ASSeqirus UK Limited
2013-07-04Pandemic influenza vaccine (Nasjonalt folkehelseinstitutt)
The Norwegian Institute of Public Health (NIPH), on behalf of the Norwegian Ministry of Health and Care Services, will conduct a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of this tender is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period. The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period. The …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline ASNovartis Norge AS